Log In
BCIQ
Print this Print this
 

MVA-BN PRO, MVA-BN Prostate cancer vaccine

  Manage Alerts
Collapse Summary General Information
Company Bavarian Nordic A/S
DescriptionModified vaccinia Ankara (MVA) vector vaccine against prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP)
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationProstate cancer
Indication DetailsVaccinate against prostate cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today